🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The European guidelines emphasize the importance of conducting psychologica...
Status
Completed
Location
ICS Maugeri SpA SB
Start Date
2023-01-31
Trial ID
NCT06396793
Treatments Being Tested
Behçet's disease (BD) is an autoimmune, rare, and severe multisystemic infl...
Status
Unknown
Location
AOUPisana
Start Date
2021-11-16
Trial ID
NCT05128357
Treatments Being Tested
SBRT, atezolizumab, and bevacizumab have different mechanisms of action and...
Status
Unknown
Location
Institute of Liver & Biliary Sciences
Start Date
2024-02-05
Trial ID
NCT06244446
Treatments Being Tested
This is a prospective, multicenter real-world study to describe the postope...
Status
Recruiting
Location
Research Site
Start Date
2026-03-19
Trial ID
NCT07446738
Treatments Being Tested
The objectives of the current study are to identify and evaluate new progno...
Status
Completed
Location
Department of Respiratory Medicine, University Medical Center Hamburg-Eppendorf
Start Date
2010-10
Trial ID
NCT01317134
Treatments Being Tested
The hypothesis of this study is that "the poor metabolizer or intermediate ...
Status
Completed
Location
Yongin Severance Hospital
Start Date
2019-09-20
Trial ID
NCT04072705
Treatments Being Tested
The goal of this observational study is to evaluate and validate the expres...
Status
Active Not Recruiting
Location
Peking University First Hospital
Start Date
2026-01-01
Trial ID
NCT07597369
Treatments Being Tested
This study seeks to compare the effectiveness of two medications used to tr...
Status
Completed
Location
Yale University School of Medicine
Start Date
2021-01-07
Trial ID
NCT04219540
Treatments Being Tested
Child-parent screening for familial hypercholesterolemia has been proposed ...
Status
Recruiting
Location
Anhui Provincial Children's Hospital
Start Date
2025-04-01
Trial ID
NCT04529967
Treatments Being Tested
Envafolimab is a novel PD-L1 inhibitor administered via subcutaneous (SC) i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07562347
Treatments Being Tested